rosiglitazone has been researched along with agar in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boeglin, WE; Brash, AR; Case, T; Dubois, RN; Gupta, RA; Jack, GS; Manning, S; Matusik, RJ; Price, J; Schneider, C; Shappell, SB; Wheeler, TM; Whitehead, R | 1 |
Andreeff, M; Chism, D; Collins, SJ; Elstner, E; Hu, W; Koeffler, HP; Konopleva, M; Kornblau, SM; McQueen, TJ; Schober, WD; Sudarikov, A; Tsao, T; Wang, RY; Younes, A | 1 |
2 other study(ies) available for rosiglitazone and agar
Article | Year |
---|---|
15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Topics: Agar; Arachidonate 15-Lipoxygenase; Blotting, Northern; Catalysis; Cell Division; Culture Media; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydroxyeicosatetraenoic Acids; Isoenzymes; Luciferases; Male; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
Topics: Agar; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Dimerization; Fibrinolytic Agents; Flow Cytometry; HL-60 Cells; Humans; Imidazoles; Immunologic Factors; Jurkat Cells; Leukemia; Ligands; Oleanolic Acid; Phagocytosis; Plasmids; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Transcriptional Activation; Transfection; U937 Cells | 2004 |